Impact of Epstein–Barr virus load, virus genotype, and frequency of the 30 bp deletion in the viral BNLF‐1 gene in patients harboring the human immunodeficiency virus

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Medical Virology

• Publication date

  2013-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jmv.23722PMID 24014234
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distinctive Epstein-Barr Virus Variants Associated with Benign and Malignant Pediatric Pathologies: LMP1 Sequence Characterization and Linkage with Other Viral Gene Polymorphisms

  2011cited by this paper
• Clinical characteristics, outcome and the role of viral load in nontransplant patients with Epstein-Barr viraemia.

  2010cited by this paper
• Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye

  2010cited by this paper
• Three Epstein–Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints

  2009cited by this paper
• The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.

  2009cited by this paper
• Measuring Epstein–Barr virus (EBV) load: the significance and application for each EBV‐associated disease

  2008cited by this paper
• Herpesvirus prevalence and viral load in healthy blood donors by quantitative real‐time polymerase chain reaction

  2008cited by this paper
• Detection of Herpesvirus DNA in Cerebrospinal Fluid and Correlation with Clinical Symptoms

  2008cited by this paper
• High Levels of Epstein-Barr Virus DNA in Latently Infected Gastric Adenocarcinoma

  2008cited by this paper
• Polymorphism analysis of Epstein-Barr virus isolates of nasopharyngeal carcinoma biopsies from Tunisian patients

  2007cited by this paper
• AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era

  2007cited by this paper
• Epstein Barr virus genotypes and LMP‐1 variants in HIV‐infected patients

  2007cited by this paper
• Concurrent CMV and EBV DNAemia Is Significantly Correlated with a Delay in the Response to HAART in Treatment-Naive HIV Type 1-Positive Patients

  2007cited by this paper
• Changes in acquired immunodeficiency syndrome‐related non‐Hodgkin lymphoma in the era of highly active antiretroviral therapy

  2006cited by this paper
• HIV infection and lymphoma

  2006cited by this paper
• Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.

  2006cited by this paper
• Human Endogenous Retrovirus (HERV)-R family in primates: Chromosomal location, gene expression, and evolution.

  2006cited by this paper
• The genome of Epstein-Barr virus type 2 strain AG876.

  2006cited by this paper
• Reconstitution of EBV Latent but Not Lytic Antigen-Specific CD4+ and CD8+ T Cells after HIV Treatment with Highly Active Antiretroviral Therapy 1

  2005cited by this paper
• Epstein–Barr viral load as a marker of lymphoma in AIDS patients

  2005cited by this paper
• EBV the prototypical human tumor virus--just how bad is it?

  2005cited by this paper
• AIDS and associated malignancies

  2005cited by this paper
• Epstein–Barr virus: 40 years on

  2004cited by this paper
• Epstein-Barr Virus and Cancer

  2004cited by this paper
• Epstein‐barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein‐1 (LMP‐1) oncogene

  2004cited by this paper
• Altered EBV Viral Load Setpoint after HIV Seroconversion Is in Accordance with Lack of Predictive Value of EBV Load for the Occurrence of AIDS-Related Non-Hodgkin Lymphoma1

  2004cited by this paper
• Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy.

  2003cited by this paper
• Molecular Parameters for Precise Diagnosis of Asymptomatic Epstein-Barr Virus Reactivation in Healthy Carriers

  2003cited by this paper
• High Epstein–Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology

  2002cited by this paper
• The incidence of lymphoma in the UK haemophilia population between 1978 and 1999

  2002cited by this paper
• Epstein‐Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV‐infected patients treated with HAART

  2002cited by this paper
• LMP1 structure and signal transduction.

  2001cited by this paper
• Quantification of Epstein‐Barr virus load in peripheral blood of human immunodeficiency virus‐infected patients using real‐time PCR

  2001cited by this paper
• AIDS and cancer in the era of highly active antiretroviral therapy (HAART).

  2001cited by this paper
• Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy.

  2001cited by this paper
• Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy

  2001cited by this paper
• Epstein–Barr Virus and Cancer

  2001cited by this paper
• Epstein-Barr Virus LMP-1 Natural Sequence Variants Differ in Their Potential To Activate Cellular Signaling Pathways

  2001cited by this paper
• A quantification of human cells using an ERV-3 real time PCR assay.

  2001cited by this paper
• Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

  2000cited by this paper
• The expression and function of Epstein-Barr virus encoded latent genes

  2000cited by this paper
• High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission.

  2000cited by this paper
• Quantitative Analysis of Epstein-Barr Virus Load by Using a Real-Time PCR Assay

  1999cited by this paper
• Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: reliable markers for individual strain identification.

  1999cited by this paper
• Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study

  1999cited by this paper
• Direct Epstein-Barr virus (EBV) typing on peripheral blood mononuclear cells: no association between EBV type 2 infection or superinfection and the development of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma.

  1999cited by this paper
• Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers.

  1999cited by this paper
• Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses.

  1999cited by this paper
• The 30-Base-Pair Deletion in Chinese Variants of the Epstein-Barr Virus LMP1 Gene Is Not the Major Effector of Functional Differences between Variant LMP1 Genes in Human Lymphocytes

  1998cited by this paper
• Epidemiology of Infection with Epstein-Barr Virus Types 1 and 2: Lessons from the Study of a T-Cell-Immunocompromised Hemophilic Cohort

  1998cited by this paper
• Tissue distribution of Epstein‐Barr virus genotypes in hosts coinfected by HIV

  1998cited by this paper
• Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus.

  1998cited by this paper
• Natural 30 base pair and 69 base pair deletion variants of the LMP1 oncogene do stimulate NF-κB-mediated transcription

  1997cited by this paper
• Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals

  1996cited by this paper
• Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Type A with a high prevalence of deletions within the latent membrane protein gene.

  1996cited by this paper
• Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection.

  1994cited by this paper
• Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas.

  1994cited by this paper
• Epstein-Barr virus infection in HIV-positive patients

  1993cited by this paper
• 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

  1993cited by this paper
• Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma.

  1991cited by this paper
• Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments

  1981cited by this paper
• VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

  1964cited by this paper

• MOLECULAR AND GENETIC CHARACTERISTICS OF EPSTEIN-BARR VIRUS ISOLATES IN ADULT PATIENTS WITH HIV INFECTION IN NIZHNY NOVGOROD REGION

  2025cites this paper
• Quantitatively assessed blood leukocyte Epstein–Barr virus in adult HIV-infected patients

  2024cites this paper
• ASSESSMENT OF THE RELATIONSHIP BETWEEN EPSTEIN-BARR VIRUS MAJOR TYPES AND GENOVARIANTS AS WELL AS CLINICAL AND LABORATORY PARAMETERS IN HIV-INFECTED ADULTS

  2024cites this paper
• Genotype characterization of Epstein–Barr virus among adults living with human immunodeficiency virus in Ethiopia

  2023cites this paper
• Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region

  2021cites this paper
• The Role of Coinfections in the EBV–Host Broken Equilibrium

  2021cites this paper
• Viral etiology of sporadic cases of parotitis among children in Korea during 2013‐2014

  2018cites this paper
• Epstein-Barr Virus Strain Variation.

  2015cites this paper